A machine scanned one writer’s entire body, found 1,596 skin markings, checked his heart and blood, and handed him answers before he even left the building. It took 60 minutes.
Quick Take
- Neko Health’s body scan uses cameras, sensors, and blood tests to check skin, heart, and circulation in about an hour, with no needles or radiation.
- The company opened its first United States location in New York City on September 24, 2026, after more than 25,000 New Yorkers joined the waitlist.
- A single scan costs $499 and is eligible for Health Savings Account (HSA) and Flexible Spending Account (FSA) payment.
- Doctors and researchers warn that similar whole-body screening tools can produce false alarms and unnecessary follow-up testing.
What The Scan Actually Does In One Hour
Neko Health built a machine that photographs the skin from every angle, tracks heart signals, and reads blood markers, all in a single visit. The company says the scan “captures millions of health data points” without cutting, radiation, or a long wait for lab results. A Men’s Health writer who tried it had 1,596 individual skin markings mapped and reviewed with a clinician on the spot.
From Stockholm Startup To New York Storefront
Spotify co-founder Daniel Ek and Hjalmar Nilsonne launched Neko Health in Stockholm back in February 2023, betting that people would pay out of pocket for fast, visual health data. The company grew fast. It raised $260 million in January 2025, then $700 million more in July 2026 to fund its push into the United States.
New York became the company’s first American stop, opening its doors at 300 Lafayette Street in SoHo on September 24, 2026. More than 25,000 New Yorkers had already joined the waitlist before the doors opened, a sign that Americans are hungry for a faster, more visual way to check their own health.
What A Customer Actually Pays And Gets
The scan runs $499 and qualifies for HSA or FSA dollars, meaning many Americans can use pre-tax money already set aside for medical costs. In June 2026, Neko added body composition tracking and wearable device integration, deepening the data pool beyond skin, heart, and blood. Results appear on-site within minutes, followed by a face-to-face talk with a medical professional rather than a mailed report weeks later.
Why Some Reviewers Walked Away Impressed
A Cosmopolitan writer who paid £299 for the United Kingdom version called it a “hardcore” recommendation after her session. Online video reviewers have echoed that reaction, filming their own scans and calling out the novelty of watching a machine map their skin in real time. The appeal is simple: instead of guessing what a doctor might find someday, customers walk out with a printed picture of their own biology that same hour.
The Bigger Debate Over Whole-Body Screening
Neko’s scan lands in the middle of a much older argument in medicine. Whole-body screening tools, including MRI-based scans, have shown a pooled false-positive rate near 16 percent in past reviews, meaning some findings turn out to be nothing at all. The American Medical Association has said these kinds of scans “have not been scientifically validated for screening purposes,” and has called for more research before Americans lean on them for peace of mind.
Other researchers point to a similar pattern with full-body MRI: one review found 95 percent of healthy people had at least one “abnormal” finding, yet 91 percent of those findings turned out to be irrelevant. That gap between data collected and disease actually prevented is the central tension for any preventive screening product, Neko included. More information does not automatically mean better health decisions, especially when a flagged mole or reading sends someone chasing tests that lead nowhere.
What This Means For Health-Conscious Americans
Cochrane, a respected medical research group, has found that general health checks offered broadly to healthy people are unlikely to change how long they live and may lead to needless extra testing. That does not mean Neko’s scan has no value. Catching one serious skin lesion early, for one customer, could matter enormously. But buyers should walk in knowing that a clean bill of data is not the same guarantee as a clean bill of health, and that follow-up testing costs time and money the marketing brochure does not mention.
Neko Health represents the latest version of an old American instinct: pay for certainty, get it fast, and trust the numbers on the screen. For patients with the means and the curiosity, an hour-long scan may be worth the price of admission. For everyone else, the smarter move is treating it as one more data point, not a replacement for a doctor who knows your history and can weigh what the scan cannot show.
Sources:
menshealth.com, nekohealth.com, prnewswire.com, longevity.technology, www1.racgp.org.au, webmd.com, fredhutch.org, cancercenter.com
